Stock Taper
EARNINGS CALL ARCHIVE 2 CALLS ON FILE
MESO — Mesoblast Limited
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

FEB 27, 2026
REVENUE
$25.7M 0.0%
NET MARGIN
-78.2% 0.0 PTS
EPS
-$0.15 0.0%
FREE CASH FLOW
-$15.7M -2.9%

No summary has been written for this call yet.